{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The merger proxy for Mallinckrodt&#8217;s $5.6 billion bid for Questcor Pharmaceuticals does not include reports of incidents involving Acthar, Questcor&#8217;s immune-system drug and its biggest product.", "headline": {"main": "Drug Merger Discussion Leaves Out a Key Risk", "print_headline": "Drug Merger Discussion Leaves Out a Key Risk"}, "abstract": "Merger proxy for Mallinckrodt\u2019s $5.6 billion bid for Questcor Pharmaceuticals does not include reports of incidents involving Acthar, immune-system drug that is Questcor\u2019s biggest product; incidents include 20 deaths and six disabilities since 2012; issue is just one of many hanging over Questcor, which also faces inquiries concerning marketing practices and labeling.", "print_page": "1", "word_count": "1371", "_id": "539a026e7988106c3c7765d7", "snippet": "The merger proxy for Mallinckrodt&#8217;s $5.6 billion bid for Questcor Pharmaceuticals does not include reports of incidents involving Acthar, Questcor&#8217;s immune-system drug and its biggest product.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/13/business/a-drugs-risks-are-left-out-in-discussion-of-questcor-deal.html", "multimedia": [{"subtype": "wide", "url": "images/2014/06/13/business/13quest-pic/13quest-pic-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/13/business/13quest-pic/13quest-pic-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/13/business/13quest-pic/13quest-pic-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/13/business/13quest-pic/13quest-pic-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/06/13/business/13QUEST/13QUEST-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/06/13/business/13QUEST/13QUEST-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Mallinckrodt Plc.", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Questcor Pharmaceuticals Inc", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "4", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gretchen", "lastname": "MORGENSON"}], "original": "By GRETCHEN MORGENSON"}, "document_type": "article", "pub_date": "2014-06-13T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Blog", "blog": [], "news_desk": "OpEd", "lead_paragraph": null, "headline": {"main": "The Power to Cure, Multiplied", "kicker": "Fixes"}, "abstract": "Project ECHO is a \u201cdisruptive innovation\u201d that uses video to train clinicians to perform like specialists in underserved areas. Used more widely it could transform health care.", "print_page": null, "word_count": "2359", "_id": "539876577988104e442a7e31", "snippet": "Project ECHO is a \u201cdisruptive innovation\u201d that uses video to train clinicians to perform like specialists in underserved areas. Used more widely it could transform health care.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://opinionator.blogs.nytimes.com/2014/06/11/the-doctor-will-stream-to-you-now/", "multimedia": [{"subtype": "wide", "url": "images/2014/06/11/opinion/11fixes1/11fixes1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/11/opinion/11fixes1/11fixes1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/11/opinion/11fixes1/11fixes1-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/11/opinion/11fixes1/11fixes1-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/04/25/opinion/opinionator-pog-fixes/opinionator-pog-fixes-thumbStandard.gif", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/04/25/opinion/opinionator-pog-fixes/opinionator-pog-fixes-thumbStandard.gif", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "New Mexico", "name": "glocations", "rank": "2"}, {"value": "Albuquerque (NM)", "name": "glocations", "rank": "1"}, {"value": "Hepatitis", "name": "subject", "rank": "3"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "2"}, {"value": "Videophones and Videoconferencing", "name": "subject", "rank": "5"}, {"value": "Medicine and Health", "name": "subject", "rank": "4"}, {"value": "Doctors", "name": "subject", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "David", "lastname": "BORNSTEIN"}], "original": "By DAVID BORNSTEIN"}, "document_type": "blogpost", "pub_date": "2014-06-11T11:30:23Z", "section_name": "Opinion"}], "meta": {"hits": 2, "offset": 0, "time": 79}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}